nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—HTR1A—G alpha (i) signalling events—SST—duodenum cancer	0.00571	0.00571	CbGpPWpGaD
Bromocriptine—HTR2B—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.0056	0.0056	CbGpPWpGaD
Bromocriptine—DRD1—GPCR ligand binding—SCT—duodenum cancer	0.00556	0.00556	CbGpPWpGaD
Bromocriptine—ADRA2C—G alpha (i) signalling events—SST—duodenum cancer	0.00552	0.00552	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR ligand binding—SCT—duodenum cancer	0.00549	0.00549	CbGpPWpGaD
Bromocriptine—DRD3—GPCR ligand binding—SCT—duodenum cancer	0.00549	0.00549	CbGpPWpGaD
Bromocriptine—DRD1—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00528	0.00528	CbGpPWpGaD
Bromocriptine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00521	0.00521	CbGpPWpGaD
Bromocriptine—DRD3—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00521	0.00521	CbGpPWpGaD
Bromocriptine—DRD2—G alpha (i) signalling events—SST—duodenum cancer	0.00501	0.00501	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR ligand binding—SCT—duodenum cancer	0.005	0.005	CbGpPWpGaD
Bromocriptine—DRD5—GPCR downstream signaling—GAST—duodenum cancer	0.00499	0.00499	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR ligand binding—SCT—duodenum cancer	0.00495	0.00495	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR ligand binding—SCT—duodenum cancer	0.00478	0.00478	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR ligand binding—SCT—duodenum cancer	0.00476	0.00476	CbGpPWpGaD
Bromocriptine—ADRB1—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00475	0.00475	CbGpPWpGaD
Bromocriptine—DRD5—GPCR downstream signaling—SCT—duodenum cancer	0.00473	0.00473	CbGpPWpGaD
Bromocriptine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.0047	0.0047	CbGpPWpGaD
Bromocriptine—HTR6—GPCR ligand binding—SST—duodenum cancer	0.00467	0.00467	CbGpPWpGaD
Bromocriptine—HTR7—GPCR ligand binding—SST—duodenum cancer	0.00466	0.00466	CbGpPWpGaD
Bromocriptine—HTR1D—GPCR ligand binding—SST—duodenum cancer	0.00463	0.00463	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR ligand binding—SCT—duodenum cancer	0.00463	0.00463	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR ligand binding—SCT—duodenum cancer	0.00455	0.00455	CbGpPWpGaD
Bromocriptine—HTR1A—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00454	0.00454	CbGpPWpGaD
Bromocriptine—HTR1B—GPCR ligand binding—SST—duodenum cancer	0.00454	0.00454	CbGpPWpGaD
Bromocriptine—DRD5—Signaling by GPCR—GAST—duodenum cancer	0.00453	0.00453	CbGpPWpGaD
Bromocriptine—HTR2C—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00452	0.00452	CbGpPWpGaD
Bromocriptine—ADRA2A—G alpha (i) signalling events—SST—duodenum cancer	0.00449	0.00449	CbGpPWpGaD
Bromocriptine—DRD4—GPCR ligand binding—SST—duodenum cancer	0.00446	0.00446	CbGpPWpGaD
Bromocriptine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00439	0.00439	CbGpPWpGaD
Bromocriptine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00432	0.00432	CbGpPWpGaD
Bromocriptine—DRD5—Signaling by GPCR—SCT—duodenum cancer	0.00429	0.00429	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR ligand binding—SST—duodenum cancer	0.00426	0.00426	CbGpPWpGaD
Bromocriptine—DRD2—GPCR ligand binding—SCT—duodenum cancer	0.0042	0.0042	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR ligand binding—SCT—duodenum cancer	0.00413	0.00413	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR ligand binding—SCT—duodenum cancer	0.00404	0.00404	CbGpPWpGaD
Bromocriptine—DRD1—GPCR ligand binding—SST—duodenum cancer	0.00402	0.00402	CbGpPWpGaD
Bromocriptine—DRD2—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00399	0.00399	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR ligand binding—SST—duodenum cancer	0.00397	0.00397	CbGpPWpGaD
Bromocriptine—DRD3—GPCR ligand binding—SST—duodenum cancer	0.00397	0.00397	CbGpPWpGaD
Bromocriptine—HTR2A—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00392	0.00392	CbGpPWpGaD
Bromocriptine—HTR6—GPCR downstream signaling—GAST—duodenum cancer	0.00385	0.00385	CbGpPWpGaD
Bromocriptine—HTR7—GPCR downstream signaling—GAST—duodenum cancer	0.00385	0.00385	CbGpPWpGaD
Bromocriptine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00384	0.00384	CbGpPWpGaD
Bromocriptine—HTR1D—GPCR downstream signaling—GAST—duodenum cancer	0.00382	0.00382	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR ligand binding—SCT—duodenum cancer	0.00376	0.00376	CbGpPWpGaD
Bromocriptine—HTR1B—GPCR downstream signaling—GAST—duodenum cancer	0.00374	0.00374	CbGpPWpGaD
Bromocriptine—DRD4—GPCR downstream signaling—GAST—duodenum cancer	0.00368	0.00368	CbGpPWpGaD
Bromocriptine—HTR6—GPCR downstream signaling—SCT—duodenum cancer	0.00365	0.00365	CbGpPWpGaD
Bromocriptine—HTR7—GPCR downstream signaling—SCT—duodenum cancer	0.00365	0.00365	CbGpPWpGaD
Bromocriptine—HTR1D—GPCR downstream signaling—SCT—duodenum cancer	0.00362	0.00362	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR ligand binding—SST—duodenum cancer	0.00361	0.00361	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR ligand binding—SST—duodenum cancer	0.00358	0.00358	CbGpPWpGaD
Bromocriptine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00357	0.00357	CbGpPWpGaD
Bromocriptine—HTR1B—GPCR downstream signaling—SCT—duodenum cancer	0.00355	0.00355	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR downstream signaling—GAST—duodenum cancer	0.00351	0.00351	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—GAST—duodenum cancer	0.0035	0.0035	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—GAST—duodenum cancer	0.00349	0.00349	CbGpPWpGaD
Bromocriptine—DRD4—GPCR downstream signaling—SCT—duodenum cancer	0.00349	0.00349	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—GAST—duodenum cancer	0.00347	0.00347	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR ligand binding—SST—duodenum cancer	0.00346	0.00346	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR ligand binding—SST—duodenum cancer	0.00344	0.00344	CbGpPWpGaD
Bromocriptine—DRD5—GPCR downstream signaling—SST—duodenum cancer	0.00342	0.00342	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—GAST—duodenum cancer	0.0034	0.0034	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR ligand binding—SST—duodenum cancer	0.00334	0.00334	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—GAST—duodenum cancer	0.00334	0.00334	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR downstream signaling—SCT—duodenum cancer	0.00333	0.00333	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—SCT—duodenum cancer	0.00331	0.00331	CbGpPWpGaD
Bromocriptine—DRD1—GPCR downstream signaling—GAST—duodenum cancer	0.00331	0.00331	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—SCT—duodenum cancer	0.00331	0.00331	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR ligand binding—SST—duodenum cancer	0.00329	0.00329	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—SCT—duodenum cancer	0.00329	0.00329	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR downstream signaling—GAST—duodenum cancer	0.00327	0.00327	CbGpPWpGaD
Bromocriptine—DRD3—GPCR downstream signaling—GAST—duodenum cancer	0.00327	0.00327	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—SCT—duodenum cancer	0.00322	0.00322	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—GAST—duodenum cancer	0.00319	0.00319	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—SCT—duodenum cancer	0.00317	0.00317	CbGpPWpGaD
Bromocriptine—DRD1—GPCR downstream signaling—SCT—duodenum cancer	0.00314	0.00314	CbGpPWpGaD
Bromocriptine—DRD5—Signaling by GPCR—SST—duodenum cancer	0.0031	0.0031	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR downstream signaling—SCT—duodenum cancer	0.0031	0.0031	CbGpPWpGaD
Bromocriptine—DRD3—GPCR downstream signaling—SCT—duodenum cancer	0.0031	0.0031	CbGpPWpGaD
Bromocriptine—DRD2—GPCR ligand binding—SST—duodenum cancer	0.00303	0.00303	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—SCT—duodenum cancer	0.00303	0.00303	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—GAST—duodenum cancer	0.00301	0.00301	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR ligand binding—SST—duodenum cancer	0.00299	0.00299	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR downstream signaling—GAST—duodenum cancer	0.00298	0.00298	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—GAST—duodenum cancer	0.00297	0.00297	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—GAST—duodenum cancer	0.00297	0.00297	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—GAST—duodenum cancer	0.00295	0.00295	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR ligand binding—SST—duodenum cancer	0.00292	0.00292	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—SCT—duodenum cancer	0.00285	0.00285	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—GAST—duodenum cancer	0.00285	0.00285	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—GAST—duodenum cancer	0.00284	0.00284	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR downstream signaling—SCT—duodenum cancer	0.00282	0.00282	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—SCT—duodenum cancer	0.00282	0.00282	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—SCT—duodenum cancer	0.00282	0.00282	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—SCT—duodenum cancer	0.0028	0.0028	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—GAST—duodenum cancer	0.00276	0.00276	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR ligand binding—SST—duodenum cancer	0.00272	0.00272	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—GAST—duodenum cancer	0.00271	0.00271	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—GAST—duodenum cancer	0.00271	0.00271	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—SCT—duodenum cancer	0.0027	0.0027	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—SCT—duodenum cancer	0.00269	0.00269	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—GAST—duodenum cancer	0.00268	0.00268	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—GAST—duodenum cancer	0.00268	0.00268	CbGpPWpGaD
Bromocriptine—HTR6—GPCR downstream signaling—SST—duodenum cancer	0.00264	0.00264	CbGpPWpGaD
Bromocriptine—HTR7—GPCR downstream signaling—SST—duodenum cancer	0.00264	0.00264	CbGpPWpGaD
Bromocriptine—HTR1D—GPCR downstream signaling—SST—duodenum cancer	0.00262	0.00262	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—SCT—duodenum cancer	0.00261	0.00261	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—GAST—duodenum cancer	0.00259	0.00259	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—GAST—duodenum cancer	0.00257	0.00257	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—SCT—duodenum cancer	0.00257	0.00257	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—SCT—duodenum cancer	0.00257	0.00257	CbGpPWpGaD
Bromocriptine—HTR1B—GPCR downstream signaling—SST—duodenum cancer	0.00256	0.00256	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—SCT—duodenum cancer	0.00254	0.00254	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—SCT—duodenum cancer	0.00254	0.00254	CbGpPWpGaD
Bromocriptine—DRD4—GPCR downstream signaling—SST—duodenum cancer	0.00252	0.00252	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—GAST—duodenum cancer	0.0025	0.0025	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—GAST—duodenum cancer	0.0025	0.0025	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—GAST—duodenum cancer	0.00246	0.00246	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—GAST—duodenum cancer	0.00246	0.00246	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—SCT—duodenum cancer	0.00245	0.00245	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—SCT—duodenum cancer	0.00244	0.00244	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—GAST—duodenum cancer	0.00241	0.00241	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR downstream signaling—SST—duodenum cancer	0.00241	0.00241	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—SST—duodenum cancer	0.0024	0.0024	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—SST—duodenum cancer	0.00239	0.00239	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—SST—duodenum cancer	0.00238	0.00238	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—SCT—duodenum cancer	0.00237	0.00237	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—SCT—duodenum cancer	0.00237	0.00237	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—SCT—duodenum cancer	0.00234	0.00234	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—SCT—duodenum cancer	0.00233	0.00233	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—SST—duodenum cancer	0.00233	0.00233	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—SST—duodenum cancer	0.00229	0.00229	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—SCT—duodenum cancer	0.00229	0.00229	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—GAST—duodenum cancer	0.00227	0.00227	CbGpPWpGaD
Bromocriptine—DRD1—GPCR downstream signaling—SST—duodenum cancer	0.00227	0.00227	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR downstream signaling—SST—duodenum cancer	0.00224	0.00224	CbGpPWpGaD
Bromocriptine—DRD3—GPCR downstream signaling—SST—duodenum cancer	0.00224	0.00224	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—GAST—duodenum cancer	0.00224	0.00224	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—GAST—duodenum cancer	0.00224	0.00224	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—MEN1—duodenum cancer	0.00222	0.00222	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—GAST—duodenum cancer	0.00219	0.00219	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—SST—duodenum cancer	0.00219	0.00219	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—SCT—duodenum cancer	0.00215	0.00215	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—SCT—duodenum cancer	0.00212	0.00212	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—SCT—duodenum cancer	0.00212	0.00212	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—SCT—duodenum cancer	0.00208	0.00208	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—GAST—duodenum cancer	0.00207	0.00207	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—GAST—duodenum cancer	0.00206	0.00206	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—SST—duodenum cancer	0.00206	0.00206	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—GAST—duodenum cancer	0.00205	0.00205	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR downstream signaling—SST—duodenum cancer	0.00204	0.00204	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—SST—duodenum cancer	0.00204	0.00204	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—SST—duodenum cancer	0.00204	0.00204	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—GAST—duodenum cancer	0.00203	0.00203	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—SST—duodenum cancer	0.00202	0.00202	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—GAST—duodenum cancer	0.00201	0.00201	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—GAST—duodenum cancer	0.00197	0.00197	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—SCT—duodenum cancer	0.00196	0.00196	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—SCT—duodenum cancer	0.00196	0.00196	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—SST—duodenum cancer	0.00195	0.00195	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—SST—duodenum cancer	0.00194	0.00194	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—SCT—duodenum cancer	0.00194	0.00194	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—SCT—duodenum cancer	0.00193	0.00193	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—SCT—duodenum cancer	0.0019	0.0019	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—SST—duodenum cancer	0.00189	0.00189	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—GAST—duodenum cancer	0.00189	0.00189	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—SCT—duodenum cancer	0.00187	0.00187	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—SST—duodenum cancer	0.00186	0.00186	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—SST—duodenum cancer	0.00185	0.00185	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—SST—duodenum cancer	0.00184	0.00184	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—SST—duodenum cancer	0.00183	0.00183	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—SCT—duodenum cancer	0.00179	0.00179	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—GAST—duodenum cancer	0.00178	0.00178	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—SST—duodenum cancer	0.00177	0.00177	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—SST—duodenum cancer	0.00176	0.00176	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—GAST—duodenum cancer	0.00175	0.00175	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—GAST—duodenum cancer	0.00175	0.00175	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—SST—duodenum cancer	0.00172	0.00172	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—SST—duodenum cancer	0.00172	0.00172	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—MEN1—duodenum cancer	0.00171	0.00171	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—MEN1—duodenum cancer	0.00171	0.00171	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—MEN1—duodenum cancer	0.0017	0.0017	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—SST—duodenum cancer	0.00169	0.00169	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—SST—duodenum cancer	0.00169	0.00169	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—SCT—duodenum cancer	0.00169	0.00169	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—SCT—duodenum cancer	0.00166	0.00166	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—SCT—duodenum cancer	0.00166	0.00166	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—MEN1—duodenum cancer	0.00166	0.00166	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—SST—duodenum cancer	0.00165	0.00165	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—MEN1—duodenum cancer	0.00164	0.00164	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—GAST—duodenum cancer	0.0016	0.0016	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—GAST—duodenum cancer	0.00158	0.00158	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—MEN1—duodenum cancer	0.00156	0.00156	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—SST—duodenum cancer	0.00156	0.00156	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—SST—duodenum cancer	0.00154	0.00154	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—SST—duodenum cancer	0.00153	0.00153	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—GAST—duodenum cancer	0.00153	0.00153	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—GAST—duodenum cancer	0.00152	0.00152	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—SCT—duodenum cancer	0.00152	0.00152	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—SCT—duodenum cancer	0.0015	0.0015	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—SST—duodenum cancer	0.0015	0.0015	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—GAST—duodenum cancer	0.00148	0.00148	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MEN1—duodenum cancer	0.00147	0.00147	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—GAST—duodenum cancer	0.00146	0.00146	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MEN1—duodenum cancer	0.00145	0.00145	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MEN1—duodenum cancer	0.00145	0.00145	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—SCT—duodenum cancer	0.00145	0.00145	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—SCT—duodenum cancer	0.00144	0.00144	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—SST—duodenum cancer	0.00142	0.00142	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—SST—duodenum cancer	0.00141	0.00141	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—SST—duodenum cancer	0.0014	0.0014	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—SCT—duodenum cancer	0.0014	0.0014	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—SST—duodenum cancer	0.00139	0.00139	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—SCT—duodenum cancer	0.00138	0.00138	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—SST—duodenum cancer	0.00138	0.00138	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—SST—duodenum cancer	0.00135	0.00135	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—GAST—duodenum cancer	0.00134	0.00134	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MEN1—duodenum cancer	0.00132	0.00132	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—GAST—duodenum cancer	0.00132	0.00132	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MEN1—duodenum cancer	0.00131	0.00131	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—GAST—duodenum cancer	0.00129	0.00129	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—SST—duodenum cancer	0.00129	0.00129	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—SCT—duodenum cancer	0.00127	0.00127	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MEN1—duodenum cancer	0.00127	0.00127	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MEN1—duodenum cancer	0.00126	0.00126	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—SCT—duodenum cancer	0.00125	0.00125	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—SCT—duodenum cancer	0.00123	0.00123	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MEN1—duodenum cancer	0.00123	0.00123	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—SST—duodenum cancer	0.00122	0.00122	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MEN1—duodenum cancer	0.00121	0.00121	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—SST—duodenum cancer	0.0012	0.0012	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—SST—duodenum cancer	0.0012	0.0012	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—GAST—duodenum cancer	0.0012	0.0012	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—SCT—duodenum cancer	0.00114	0.00114	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MEN1—duodenum cancer	0.00111	0.00111	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—SST—duodenum cancer	0.0011	0.0011	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MEN1—duodenum cancer	0.00109	0.00109	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—SST—duodenum cancer	0.00109	0.00109	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MEN1—duodenum cancer	0.00107	0.00107	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—SST—duodenum cancer	0.00105	0.00105	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—SST—duodenum cancer	0.00104	0.00104	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—SST—duodenum cancer	0.00101	0.00101	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—SST—duodenum cancer	0.000998	0.000998	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MEN1—duodenum cancer	0.000996	0.000996	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—SST—duodenum cancer	0.00092	0.00092	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—SST—duodenum cancer	0.000905	0.000905	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—SST—duodenum cancer	0.000886	0.000886	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—SST—duodenum cancer	0.000824	0.000824	CbGpPWpGaD
